Clinical Trial Update: Ketamine for Reduction of Alcoholic Relapse [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ketamine for reducing alcoholic relapse in adults with primary alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Alcohol Use Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University College, London | Conditions: Primary Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-09-09